Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin (Driponin) for COVID-19 Prophylaxis
NCT05060666Phase 3Unknown
- Sponsor
- InfectoPharm
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by InfectoPharm. Status: unknown.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05060666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060666.